Birdwatch Note
2024-05-08 05:40:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
欧州委員会はアストラゼネカの新型コロナウイルスワクチンの販売承認を2024.5.7効力発生として2024.3.27に取り消しましたが、同社が取消を2024.3.5に申請したことを記載しています。同社の意思による取消です。https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf 欧州医薬品庁の公報は、上記取消に加え、同社が商業的理由（commercial reasons）で上記ワクチンの販売の恒久的な打切りを決定したと欧州委員会に通知したことを書いています。https://www.ema.europa.eu/en/documents/public-statement/public-statement-vaxzevria-previously-covid-19-vaccine-astrazeneca_en.pdf アストラゼネカの上記ワクチンがごくまれに血栓症を起こす可能性は、最近初めて訴訟で認めたのではなく、2021年に公表されていました。 https://www.thequint.com/news/webqoof/covishield-covid-19-vaccine-astrazeneca-vaccine-tts-risk-heart-problem-not-new-information#read-more#read-more https://web.archive.org/web/20210815102507/https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf https://www.fnn.jp/articles/-/180247
Written by A71C7604A85D2B14280723049D0EF96C5A4BA60970EA8E9221AD0EDA5AC6FEC2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1787792597194572189
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1788081547846754633
- noteId - 1788081547846754633
- participantId -
- noteAuthorParticipantId - A71C7604A85D2B14280723049D0EF96C5A4BA60970EA8E9221AD0EDA5AC6FEC2 Participant Details
- createdAtMillis - 1715146836614
- tweetId - 1787792597194572189
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 欧州委員会はアストラゼネカの新型コロナウイルスワクチンの販売承認を2024.5.7効力発生として2024.3.27に取り消しましたが、同社が取消を2024.3.5に申請したことを記載しています。同社の意思による取消です。https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf 欧州医薬品庁の公報は、上記取消に加え、同社が商業的理由（commercial reasons）で上記ワクチンの販売の恒久的な打切りを決定したと欧州委員会に通知したことを書いています。https://www.ema.europa.eu/en/documents/public-statement/public-statement-vaxzevria-previously-covid-19-vaccine-astrazeneca_en.pdf アストラゼネカの上記ワクチンがごくまれに血栓症を起こす可能性は、最近初めて訴訟で認めたのではなく、2021年に公表されていました。 https://www.thequint.com/news/webqoof/covishield-covid-19-vaccine-astrazeneca-vaccine-tts-risk-heart-problem-not-new-information#read-more#read-more https://web.archive.org/web/20210815102507/https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf https://www.fnn.jp/articles/-/180247
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-08 05:40:36 UTC (1715146836614) |
2024-05-08 13:52:33 UTC (1715176353386) |
CURRENTLY_RATED_HELPFUL | 2024-05-10 03:21:20 UTC (1715311280526) |
CURRENTLY_RATED_HELPFUL | 2024-05-08 13:52:33 UTC (1715176353386) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-08 16:03:46 -0500 | Rating Details | |
| 2024-05-08 07:28:18 -0500 | Rating Details | |
| 2024-05-08 06:27:40 -0500 | Rating Details | |
| 2024-05-08 05:03:07 -0500 | Rating Details | |
| 2024-05-08 04:48:20 -0500 | Rating Details | |
| 2024-05-08 03:23:58 -0500 | Rating Details | |
| 2024-05-08 03:15:28 -0500 | Rating Details | |
| 2024-05-08 03:08:24 -0500 | Rating Details | |
| 2024-05-08 02:57:56 -0500 | Rating Details | |
| 2024-05-08 02:40:37 -0500 | Rating Details | |
| 2024-05-08 02:29:43 -0500 | Rating Details | |
| 2024-05-08 02:11:26 -0500 | Rating Details | |
| 2024-05-08 01:58:12 -0500 | Rating Details | |
| 2024-05-08 01:53:11 -0500 | Rating Details | |
| 2024-05-08 01:52:59 -0500 | Rating Details | |
| 2024-05-08 01:24:37 -0500 | Rating Details | |
| 2024-05-08 01:05:08 -0500 | Rating Details | |
| 2024-05-08 00:41:55 -0500 | Rating Details | |
| 2024-05-10 19:01:58 -0500 | Rating Details | |
| 2024-05-08 04:55:33 -0500 | Rating Details | |
| 2024-05-08 04:48:25 -0500 | Rating Details | |
| 2024-05-08 03:36:39 -0500 | Rating Details | |
| 2024-05-08 03:32:39 -0500 | Rating Details | |
| 2024-05-08 03:27:47 -0500 | Rating Details | |
| 2024-05-08 03:10:46 -0500 | Rating Details | |
| 2024-05-08 03:09:27 -0500 | Rating Details | |
| 2024-05-08 02:37:45 -0500 | Rating Details | |
| 2024-05-08 02:35:17 -0500 | Rating Details | |
| 2024-05-08 02:14:29 -0500 | Rating Details | |
| 2024-05-08 02:06:06 -0500 | Rating Details | |
| 2024-05-08 01:57:20 -0500 | Rating Details | |
| 2024-05-08 01:51:29 -0500 | Rating Details | |
| 2024-05-08 01:49:15 -0500 | Rating Details | |
| 2024-05-08 01:47:44 -0500 | Rating Details | |
| 2024-05-08 01:00:52 -0500 | Rating Details | |
| 2024-05-09 23:37:10 -0500 | Rating Details | |
| 2024-05-09 23:29:40 -0500 | Rating Details | |
| 2024-05-16 04:06:43 -0500 | Rating Details | |
| 2024-05-09 23:21:01 -0500 | Rating Details | |
| 2024-05-08 20:29:39 -0500 | Rating Details | |
| 2024-05-08 06:40:10 -0500 | Rating Details | |
| 2024-05-08 04:46:36 -0500 | Rating Details | |
| 2024-05-08 03:52:22 -0500 | Rating Details | |
| 2024-05-08 03:05:17 -0500 | Rating Details | |
| 2024-05-08 02:47:44 -0500 | Rating Details | |
| 2024-05-08 02:13:24 -0500 | Rating Details | |
| 2024-05-08 02:08:05 -0500 | Rating Details | |
| 2024-05-08 02:00:23 -0500 | Rating Details | |
| 2024-05-08 01:49:17 -0500 | Rating Details | |
| 2024-05-08 01:48:13 -0500 | Rating Details | |
| 2024-05-08 01:37:50 -0500 | Rating Details | |
| 2024-05-08 01:30:56 -0500 | Rating Details | |
| 2024-05-08 01:06:09 -0500 | Rating Details | |
| 2024-05-08 00:51:34 -0500 | Rating Details | |
| 2024-05-08 00:43:32 -0500 | Rating Details | |
| 2024-05-10 05:10:24 -0500 | Rating Details | |
| 2024-05-08 06:03:37 -0500 | Rating Details | |
| 2024-05-08 05:35:06 -0500 | Rating Details | |
| 2024-05-08 05:01:41 -0500 | Rating Details | |
| 2024-05-08 04:23:43 -0500 | Rating Details | |
| 2024-05-08 03:09:30 -0500 | Rating Details | |
| 2024-05-08 02:39:57 -0500 | Rating Details | |
| 2024-05-08 01:59:40 -0500 | Rating Details | |
| 2024-05-10 02:11:20 -0500 | Rating Details | |
| 2024-05-08 02:42:07 -0500 | Rating Details | |
| 2024-05-08 02:15:13 -0500 | Rating Details | |
| 2024-05-08 01:38:41 -0500 | Rating Details | |
| 2024-05-08 01:36:19 -0500 | Rating Details |